Lupin unveils generic version of joint pain drug PENNSAID in US Ruchika Sharma9 Dec 2022 2:49 PM ISTMumbai: Global pharma major Lupin Limited today announced the launch of authorized generic version of PENNSAID (Diclofenac Sodium Topical Solution),...
Spiro Gavaris appointed as President of Lupin's US Generics Business Ruchika Sharma9 Dec 2022 11:30 AM ISTMumbai: Global pharma major Lupin Limited has announced the appointment of Spiro Gavaris as President U.S. Generics business. As part of Lupin's...
Lupin rolls out Seizure drug Rufinamide in US Ruchika Sharma5 Dec 2022 3:15 PM ISTMumbai: Pharma major Lupin Limited today announced the launch of Rufinamide Tablets USP, 200 mg and 400 mg in the United States market.The...
Lupin arm acquires right to Limbitrol, Bacrocin and 7 other medicines from Bausch Health Ruchika Sharma29 Nov 2022 2:00 PM ISTMumbai: Global pharma major, Lupin Limited has announced that the company's wholly-owned subsidiary in Brazil, MedQuÃmica Indústria Farmacêutica, has...
Lupin unveils generic equivalent of Perforomist Inhalation Solution in US Ruchika Sharma29 Nov 2022 12:00 PM ISTMumbai: Global pharma major Lupin Limited today announced the launch of Formoterol Fumarate Inhalation Solution, 20 mcg/2 mL per Unit-Dose Vial in...
Lupin gets 8 USFDA observations for Mandideep facility Ruchika Sharma25 Nov 2022 11:00 AM ISTMumbai: Lupin has recently announced that the US Food and Drug Administration (USFDA) has concluded an inspection with eight observations each...
Lupin reports net profit of Rs 130 crore in Q2 Ruchika Sharma11 Nov 2022 3:30 PM ISTNew Delhi: Drug maker Lupin on Wednesday said its consolidated net profit stood at Rs 130 crore for the second quarter ended September 30, 2022.The...
Lupin gets USFDA nod for generic equivalent of Oracea Capsules Ruchika Sharma8 Nov 2022 5:30 PM ISTORACEA is a tetracycline class drug indicated for the treatment of only inflammatory lesions (papules and pustules) of rosacea in adult patients.
Lupin bags USFDA nod for generic equivalent of Slynd Tablets Ruchika Sharma4 Nov 2022 1:28 PM ISTMumbai: Global pharma major Lupin Limited today announced that the company has received tentative approval from the United States Food and Drug...
Lupin Tarapur facility gets USFDA warning letter Ruchika Sharma3 Nov 2022 1:30 PM IST"This warning letter summarises significant deviations from current good manufacturing practice (CGMP) for active pharmaceutical ingredients (API),"...
USFDA issues 5 observations for Lupin Nagpur facility Ruchika Sharma31 Oct 2022 11:32 AM ISTMumbai: Lupin has recently announced that the US Food and Drug Administration has concluded a Pre-Approval Inspection (PAI) with five observations at...
Lupin unveils Paliperidone ER Tablets in US Ruchika Sharma21 Oct 2022 11:26 AM ISTSchizophrenia is frequently associated with significant distress and impairment in personal, family, social, educational, occupational, and other...
